18/10/2025
Is there a simple way to increase the ease, accuracy and sensitivity of target detection for your oncology research?
There is. Whether you have low-frequency variants, FFPE tissue or liquid biopsy samples, nanoplate digital PCR (dPCR) uses absolute quantifications, increasing your accuracy and sensitivity. It’s also just as easy to pipette as qPCR.
What about analysis? Some say the data are easier to work with.
See for yourself in our online event on October 23: "Simplify. Accelerate. Detect: dPCR in oncology" 👉 https://tinyurl.com/k45zsa8d
We will demonstrate how dPCR detects and quantifies low-frequency variants and targets in low-abundance samples, show how The Christie NHS Foundation Trust uses dPCR to research treatment responses in liquid biopsies, and investigate how Tracer DX researches minimal residual disease testing.
